NorthCoast Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $28.9M | Sell |
50,621
-4,845
| -9% | -$2.77M | 1.05% | 22 |
|
|
2021
Q2 | $28M | Buy |
55,466
+30,282
| +120% | +$15.3M | 1% | 24 |
|
|
2021
Q1 | $11.5M | Buy |
25,184
+17,681
| +236% | +$8.07M | 0.47% | 61 |
|
|
2020
Q4 | $3.5M | Buy |
7,503
+126
| +2% | +$58.7K | 0.16% | 105 |
|
|
2020
Q3 | $3.26M | Buy |
7,377
+7
| +0.1% | +$3.09K | 0.17% | 100 |
|
|
2020
Q2 | $2.67M | Sell |
7,370
-54
| -0.7% | -$19.6K | 0.15% | 98 |
|
|
2020
Q1 | $2.11M | Buy |
+7,424
| New | +$2.11M | 0.13% | 98 |
|
|
2019
Q3 | – | Sell |
-7,048
| Closed | -$2.07M | – | 273 |
|
|
2019
Q2 | $2.07M | Sell |
7,048
-9,746
| -58% | -$2.86M | 0.13% | 104 |
|
|
2019
Q1 | $4.6M | Sell |
16,794
-60
| -0.4% | -$16.4K | 0.3% | 67 |
|
|
2018
Q4 | $3.77M | Buy |
+16,854
| New | +$3.77M | 0.29% | 66 |
|
|
2015
Q2 | – | Sell |
-462,478
| Closed | -$62.1M | – | 172 |
|
|
2015
Q1 | $62.1M | Sell |
462,478
-24,992
| -5% | -$3.36M | 2.91% | 12 |
|
|
2014
Q4 | $61.1M | Buy |
487,470
+19,782
| +4% | +$2.48M | 3% | 17 |
|
|
2014
Q3 | $56.9M | Buy |
467,688
+8,642
| +2% | +$1.05M | 2.81% | 15 |
|
|
2014
Q2 | $54.2M | Buy |
459,046
+450,610
| +5,342% | +$53.2M | 3.15% | 10 |
|
|
2014
Q1 | $1.01M | Buy |
+8,436
| New | +$1.01M | 0.07% | 124 |
|